Literature DB >> 32480210

Erratum for: Strategies for daily operating room management of ambulatory surgery centers following resolution of the acute phase of the COVID-19 pandemic.

Franklin Dexter1, Richard H Epstein2.   

Abstract

Entities:  

Year:  2020        PMID: 32480210      PMCID: PMC7253982          DOI: 10.1016/j.jclinane.2020.109936

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


× No keyword cloud information.
We recently published a narrative review of operating room management about planning ambulatory surgery for asymptomatic patients tested for COVID-19 [1]. From page 3 column 2, “SARS-CoV-2 is detected on plastic and stainless steel surfaces (e.g., in the phase I post-anesthesia care unit) for 4 days [48]. The University of Iowa's ambulatory surgery center has 12 operating rooms. Based on 4 cases per day per room and 50% of cases being general anesthetics, approximately 41% of 4-day periods would be expected to have at least one exposure event.” [1] That sentence references footnote 1. The last sentence of the footnote was written “false positive” rather than the intended “false negative.” [1] In addition, we correctly calculated the 41% probability of at least one false negative test. However, we wrote in the formula 0.9945 to the 120th power. We actually used the 96th power, as intended. Multiplying 12 rooms × 4 cases per day × 50% × 4 days = 96 cases.

Funding

None.

CRediT author statement

Dr. Dexter helped with conceptualization, methodology, writing the original draft, and reviewing and editing. Dr. Epstein helped with conceptualization and reviewing and editing.

Declaration of competing interest

None.
  1 in total

1.  Strategies for daily operating room management of ambulatory surgery centers following resolution of the acute phase of the COVID-19 pandemic.

Authors:  Franklin Dexter; Mohamed Elhakim; Randy W Loftus; Melinda S Seering; Richard H Epstein
Journal:  J Clin Anesth       Date:  2020-04-29       Impact factor: 9.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.